NOSE score rhinoplasty outcomes help turn a familiar but subjective question—“Can I breathe better?”—into a structured record of what the patient experiences. Nasal obstruction is not visible in a photograph, and a technically successful-looking nose does not automatically feel open to the person who lives with it. Patient-reported outcome measures give clinicians and researchers a consistent way to ask about blocked breathing before treatment and again during recovery.
For NOSE score rhinoplasty outcomes, three questionnaires are especially useful to understand: the Nasal Obstruction Symptom Evaluation (NOSE) scale, the 22-item Sino-Nasal Outcome Test (SNOT-22), and the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS). They overlap, but they are not interchangeable. NOSE is tightly focused on obstruction; SNOT-22 takes a broader view of sinonasal symptoms and quality of life; SCHNOS separates obstruction from cosmetic concerns in rhinoplasty patients. Reading them well requires more than looking for a larger or smaller number.
Why breathing outcomes need a patient voice
A nasal examination can identify a deviated septum, turbinate enlargement, scar-related narrowing, or a nasal sidewall that collapses during inspiration. Depending on the situation, a clinician may also use endoscopy or selected airflow testing. Those findings matter, but they do not fully capture the burden of symptoms: whether someone avoids exercise, wakes with a dry mouth, struggles at night, or feels constantly aware of inadequate airflow.
That is where a patient-reported outcome measure, often shortened to PROM, is valuable. It asks the same defined questions in a repeatable format, allowing a baseline score to be compared with a later score. In research, this reduces reliance on a surgeon’s impression alone. In individual care, it can make a follow-up discussion more precise: has the symptom burden changed, when did it change, and does the score fit the examination and the patient’s daily life?
A PROM is not an airflow meter, a diagnosis, or a promise. Nasal symptoms can change with allergy, viral illness, rhinitis treatment, nasal cycling, sleep, medications, healing, and expectation. A questionnaire reports the patient’s experience of those symptoms, which is clinically important, but it cannot on its own identify the cause. The evidence overview of cosmetic and functional rhinoplasty overlap explains why a functional claim should begin with diagnosis rather than appearance alone.
NOSE: the focused obstruction questionnaire
The NOSE scale was developed for people with nasal obstruction and is widely used in septoplasty and functional rhinoplasty studies. It contains five questions about obstruction-related difficulty, including congestion or stuffiness, blockage, trouble breathing through the nose, difficulty getting enough air during exertion, and sleep-related difficulty. Each item is rated from 0 to 4; the raw total is commonly multiplied by five to create a 0-to-100 score.
The direction is essential: lower NOSE scores represent fewer obstruction symptoms. A score falling from baseline after treatment therefore signals that the patient reports less obstruction on this instrument. It does not mean the nose is cosmetically improved, that every airway structure is normal, or that a particular operation caused every part of the change. Patients and readers should always check whether a study reports raw scores or the transformed 0-to-100 scale, and whether it compares the same patients before and after treatment.
NOSE is useful because it is brief and specific. It is also deliberately narrow. It does not ask about sinus pressure, smell, mood, sleep quality in depth, or satisfaction with nasal appearance. That makes it a strong choice when obstruction is the primary question, but not a complete portrait of rhinoplasty recovery. If a study uses NOSE alone, the careful conclusion is that obstruction symptoms changed—not that every functional, emotional, or cosmetic outcome changed.
A 2017 systematic review and meta-analysis of functional rhinoplasty studies found average NOSE-score reductions of roughly 43 to 50 points through at least 12 months among groups with moderate-to-severe symptoms at baseline. That finding is encouraging for appropriately selected patients with nasal-valve surgery, but the review also reported substantial heterogeneity and relied largely on observational research. An average improvement is not an individual forecast, and it does not establish that one graft, incision, or technique is best for every obstructed nose.
SNOT-22: a broader symptom and quality-of-life lens
SNOT-22 is broader than NOSE. The 22-item Sino-Nasal Outcome Test was developed for sinonasal disease and asks about nasal symptoms alongside issues such as sleep, fatigue, ear or facial symptoms, and emotional effects. Each item is scored from 0 to 5, producing a total from 0 to 110. Here too, lower scores generally indicate less symptom burden.
Because SNOT-22 is not an obstruction-only questionnaire, it can reveal whether treatment is associated with changes that matter beyond airflow. That breadth is useful when symptoms are mixed or when researchers want to understand quality of life. It also creates an interpretive limit: a total SNOT-22 score can be affected by problems that rhinoplasty or septoplasty is not designed to treat. A high score may reflect rhinitis, sinus disease, sleep disruption, other health concerns, or a combination, rather than a single structural blockage.
The NAIROS multicentre randomised trial compared septoplasty with defined medical management in adults with at least moderately severe obstruction linked to a deviated septum. Its primary patient-reported endpoint was SNOT-22 at six months, and the septoplasty group had better average outcomes. That result supports careful use of septoplasty for selected adults with symptomatic septal deviation; it should not be stretched into a claim that septal surgery fixes nasal-valve collapse, allergy, chronic rhinosinusitis, or every reason a person feels blocked.
For septorhinoplasty, SNOT-22 can complement NOSE rather than replace it. A prospective study has found the two instruments correlated in patients treated for obstruction associated with septal deviation and/or turbinate hypertrophy, while their different scopes remained clinically meaningful. Put simply, NOSE answers a more focused breathing question; SNOT-22 asks how a broader set of sinonasal symptoms affects life. A responsible article or consultation names the tool instead of describing all questionnaire results as “breathing scores.”
SCHNOS: keeping obstruction and cosmesis separate
SCHNOS was designed for rhinoplasty because form and function often interact without being the same outcome. The 10-item Standardized Cosmesis and Health Nasal Outcomes Survey has two independently reported domains: four obstruction items (SCHNOS-O) and six cosmetic items (SCHNOS-C). The obstruction domain is scored on a 0-to-100 scale from four 0-to-5 responses; the cosmetic domain is likewise transformed from six 0-to-5 responses. Lower scores indicate less concern in the relevant domain.
This split is one of SCHNOS’s most helpful features. A patient may report substantially less obstruction while still having a cosmetic concern, or be pleased with a visible change while reporting no functional benefit. Neither pattern is contradictory. It is a reminder that “successful rhinoplasty” should be defined with the patient’s actual goals, not compressed into a single before-and-after image or one blended score.
In the original SCHNOS validation study, the obstruction and cosmetic domains showed excellent internal consistency, and the obstruction subscale correlated strongly with NOSE. The domains themselves were only weakly related, which supports reporting them separately rather than assuming improved shape and improved breathing travel together. SCHNOS has also been translated and validated in several languages, including Turkish. Proper translation matters for international patients: a questionnaire should be culturally adapted and validated, not simply converted word for word.
Readers who want the wider framework for appearance and function can continue to rhinoplasty outcome measures including ROE and FACE-Q. That article explains why appearance-specific tools and broader quality-of-life scales add information that an obstruction questionnaire cannot supply.
How to compare scores fairly
The most useful comparison is usually a person’s own baseline with a planned follow-up score on the same instrument. Comparing one patient’s NOSE score with another person’s SNOT-22 total is not meaningful, and even two NOSE scores need context: were they measured during an allergy flare, before a cold, after splint removal, or at a stable later visit? The questionnaire, language version, scoring method, and timing should be recorded consistently.
Early recovery deserves special caution. Packing, splints, crusting, swelling, and normal tissue healing can temporarily make nasal breathing feel worse. A score collected very soon after surgery is a recovery snapshot, not a final verdict. The practical rhinoplasty results timeline can help patients understand why the visual and functional course of healing is not linear, but an individual care team should decide what symptoms need examination sooner rather than later.
Researchers may discuss statistical significance, minimal clinically important differences, confidence intervals, and response rates. These concepts matter because a numerical change can be statistically detectable without being equally important to every patient, while a personally meaningful change may not look dramatic in a small study. The best papers state who was studied, what operation they received, their baseline severity, follow-up duration, missing-data rate, and the limits of the design.
What these questionnaires cannot tell you
NOSE, SNOT-22, and SCHNOS do not diagnose a deviated septum, prove dynamic nasal-valve collapse, or distinguish structural obstruction from inflammatory rhinitis by themselves. They do not replace examination, and they cannot determine whether a person needs medication, surgery, or neither. They also cannot establish that cosmetic rhinoplasty will improve breathing. A lower post-treatment obstruction score is important evidence of patient experience, but it must be interpreted with the history and clinical findings.
They are not a quality ranking for surgeons or clinics either. Scores can vary with case complexity, baseline severity, follow-up practices, questionnaire language, and who completes the survey. Comparing marketing claims that cite one postoperative number without a baseline, method, sample size, or timeframe is not evidence-based. The patient-friendly guide to whether rhinoplasty can improve breathing is a useful companion when considering what a diagnosis-led discussion should cover.
Finally, questionnaires do not replace safety follow-up. New or worsening obstruction, bleeding, fever, increasing pain, a concerning wound change, or symptoms that feel urgent should be assessed through the appropriate clinical route rather than saved for a later survey. This article offers health information, not personal diagnosis or emergency advice.
Questions patients can ask about breathing outcomes
- What do you think is causing my obstruction: septum, valve, turbinates, inflammation, prior surgery, or more than one factor?
- Which questionnaire fits my concern, and will I complete it before treatment as well as during follow-up?
- Does a lower score mean fewer symptoms on this specific instrument?
- Which parts of the proposed plan are functional, and which are cosmetic?
- How will examination and, where appropriate, other tests be used alongside my questionnaire responses?
- What symptoms should lead me to seek assessment rather than waiting for the next scheduled score?
Bottom line
NOSE, SNOT-22, and SCHNOS make breathing-related outcomes more visible because they ask patients about their own symptoms over time. NOSE is the focused obstruction measure, SNOT-22 captures a wider sinonasal and quality-of-life burden, and SCHNOS reports obstruction and cosmetic concerns as separate domains. Across functional rhinoplasty research, lower postoperative obstruction scores are often reported, but study designs, diagnoses, and procedures vary. These measures are most useful when they begin before treatment, are repeated at meaningful follow-up points, and are interpreted alongside—not instead of—careful clinical assessment.
